About Index Trending news
Analyze
Top 50 Pricing
Alnylam

Alnylam

Work at Alnylam? Add yourself to this profile

Alnylam

Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.

Elsewhere

Alexa global traffic share

Twitter followers

13 Jan 2014
$700,000,000
Post-IPO equity
28 Mar 2011
$10,000,000
Venture capital